Xaira Therapeutics
The AI in Residence program at Xaira Therapeutics is a highly selective, industry‑alternative postdoctoral role where researchers and engineers apply advanced machine learning to end‑to‑end drug discovery problems. Residents collaborate with AI scientists, research engineers, and drug discovery teams to design, build, and ship ML models and pipelines that directly influence therapeutic programs.
Headquarters
Lafayette, California, United States
Company Size
1-10 employees
Founded
2023
Xaira Therapeutics is a drug discovery and development company that uses artificial intelligence to accelerate the creation of life‑changing medicines. They build computational methods, models, datasets, platforms and disciplined processes to transform drug discovery from an artisanal craft into an engineering discipline with greater certainty and success. Xaira leverages these AI‑driven approaches to generate novel therapeutics aimed at delivering better outcomes for patients in need.
How AI is Driving Drug Discovery: Xaira Therapeutics' Marc Tessier Lavigne
1 month ago
Xaira Therapeutics Releases Largest Perturb-Seq Dataset to Power the Virtual Cell
Jun 17, 2025
Xaira Therapeutics Announces the Appointment of Jeff Jonker as President and Chief Operating Officer
Jul 9, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Xaira Therapeutics.
111% above the average for this role
Reinventing Drug Discovery with AI: Marc Tessier-Lavigne on The Long Run
Nov 12, 2025
Principal Scientist, Computational Chemistry
Eikon Therapeutics
Computational Structural Biologist
AstraZeneca
Head of AI/ML Therapeutic Design
Flagship Pioneering, Inc.
Senior/Principal AI Scientist for Large Molecule - AIDD
Roche
Research Scientist II/Senior, Discovery ML
Iambic Therapeutics
Several Postdoctoral researcher and 1-2 doctoral researcher positions in machine learning in Kaski Lab, ELLIS Institute Finland and Manchester Centre for AI Fundamentals
Aalto University